)
Visual24 Oct 2025
The rise of Alphabet
Corcept Therapeutics (CORT) investor relations material
Corcept Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary31 Jul, 2025
Executive summary
Q2 2025 revenue reached $194.4M, up 18.7%–19% year-over-year, with net income at $35.1M, nearly flat from the prior year.
Record growth in endocrinology/hypercortisolism, with new prescribers and patients, but pharmacy capacity constraints limited revenue growth.
Operating income was $31.7M, down from $41.6M, reflecting higher R&D and SG&A expenses.
Multiple clinical milestones achieved, including pivotal trial publications and NDA submissions for relacorilant in hypercortisolism and ovarian cancer.
Cash and investments totaled $515M as of June 30, after significant stock repurchases.
Financial highlights
Q2 2025 product revenue: $194.4M, up 18.7%–19% year-over-year; net income $35.1M, diluted EPS $0.29 (down from $0.32).
Operating expenses rose to $167.8M from $128.2M year-over-year, driven by R&D and SG&A.
Cash and investments at quarter-end: $515M, down from $570.8M sequentially.
Gross margin remained high, with cost of sales at 1.8% of revenue.
Stock repurchases totaled $115M–$130.5M in Q2/H1 2025.
Outlook and guidance
2025 revenue guidance revised to $850M–$900M.
Pharmacy capacity expected to improve in H2 2025, with a second pharmacy operational in Q4.
Relacorilant approval in hypercortisolism anticipated by year-end, oncology approval expected next year.
BELLA and MONARCH trial results expected within the next year.
Management expects higher R&D and SG&A expenses as clinical programs advance.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Corcept Therapeutics earnings date
Q3 202529 Oct, 2025
Next Corcept Therapeutics earnings date
Q3 202529 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Corcept Therapeutics Incorporated is a pharmaceutical company focused on developing and commercializing therapies that modulate the effects of cortisol. The company targets endocrine disorders, cancer, and psychiatric conditions with proprietary small-molecule compounds. The company is headquartered in Menlo Park, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage